Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Circadian Health Regulation and Optimization for Rejuvenation Outcomes: The CHRONO Study

NCT07203196 is registered in ClinicalTrials.gov with Salk Institute for Biological Studies as lead sponsor.

NCT NCT07203196
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07203196 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Circadian Health Regulation and Optimization for Rejuvenation Outcomes: The CHRONO Study
Lead sponsor
Salk Institute for Biological Studies
Phase
Not applicable
Overall status
Active, not recruiting
Start date
October 22, 2025
Completion date
April 1, 2026
Enrollment
16 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aging, healthy, blood sugar (glucose) control, blood sugar; high, circadian dysregulation, time restricted eating